Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Ginkgo Bioworks (DNA) Short Interest Ratio & Short Volume

Ginkgo Bioworks logo
$7.35 -0.02 (-0.26%)
Closing price 05/19/2026 03:59 PM Eastern
Extended Trading
$7.44 +0.09 (+1.27%)
As of 05/19/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Ginkgo Bioworks Short Interest Overview

As of April 30, 2026, Ginkgo Bioworks (DNA) had a short interest of 5.23 million shares sold short, representing 9.68% of the public float. This marks a -14.19% decrease in short interest since the prior report. The short interest ratio (days to cover) is 5.0, meaning it would take 5.0 days of the average trading volume of 1.34 million shares to cover all short positions.

Current Short Interest
5,233,195 shares
Previous Short Interest
6,098,868 shares
Change Vs. Previous Month
-14.19%
Dollar Volume Sold Short
$44.20 million
Short Interest Ratio
5.0 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
65,320,000 shares
Short Percent of Float
9.68%
Today's Trading Volume
824,720 shares
Average Trading Volume
1,341,020 shares
Today's Volume Vs. Average
61%
Short Selling Ginkgo Bioworks?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Ginkgo Bioworks and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DNA Short Interest Over Time

DNA Days to Cover Over Time

DNA Percentage of Float Shorted Over Time

Ginkgo Bioworks Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20265,233,195 shares $44.20 million -14.2%9.7%4.95 $8.45
4/15/20266,098,868 shares $47.54 million -0.8%10.9%5.82 $7.80
3/31/20266,146,646 shares $37.65 million -23.2%11.0%5.17 $6.13
3/13/20268,004,118 shares $54.63 million +6.9%14.3%5.77 $6.83
2/27/20267,485,937 shares $50.12 million +3.1%13.7%6.82 $6.70
2/13/20267,260,233 shares $67.70 million +8.4%13.3%4.82 $9.33
1/30/20266,697,546 shares $60.34 million -4.7%12.2%8.36 $9.01
1/15/20267,027,821 shares $67.33 million +5.3%12.8%7.82 $9.58
12/31/20256,673,139 shares $55.19 million +2.8%12.2%6.63 $8.27
12/15/20256,493,151 shares $56.19 million -2.0%11.9%6.57 $8.65
11/28/20256,628,250 shares $61.48 million -5.9%12.1%6.62 $9.28
11/14/20257,043,448 shares $56.82 million -1.7%12.9%4.77 $8.07
10/31/20257,165,316 shares $93.13 million +7.7%13.4%5.91 $13.00
10/15/20256,650,000 shares $105.04 million +13.9%16.4%4.1 $15.80
9/30/20255,840,000 shares $85.21 million -6.9%14.4%3.4 $14.59
9/15/20256,270,000 shares $64.39 million -6.6%15.5%3.7 $10.27
8/31/20256,710,000 shares $85.29 million -5.5%16.6%4 $12.71
8/15/20257,100,000 shares $93.44 million -13.9%17.5%4.6 $13.16
7/31/20258,250,000 shares $108.10 million -20.2%20.7%5.7 $13.10
7/15/202510,340,000 shares $97.46 million -14.0%27.1%7.5 $9.43
6/30/202512,020,000 shares $135.71 million +6.3%31.5%9 $11.29
6/15/202511,310,000 shares $101.10 million -4.3%29.7%9.3 $8.94
5/31/202511,820,000 shares $82.27 million +2.9%31.6%9.6 $6.96
5/15/202511,490,000 shares $88.36 million -1.2%30.7%8 $7.69
4/30/202511,630,000 shares $85.71 million -12.8%31.1%7.1 $7.37
4/15/202513,340,000 shares $110.48 million +17.0%36.1%8 $8.28
3/31/202511,400,000 shares $65.04 million +14.2%30.8%6.9 $5.71
3/15/20259,980,000 shares $69.81 million +10.2%27.0%6 $7.00
2/28/20259,060,000 shares $74.25 million +3.5%24.5%5.3 $8.20
2/15/20258,750,000 shares $128.84 million +6.1%24.0%5.4 $14.73
1/31/20258,250,000 shares $110.10 million +5.4%22.6%5.5 $13.35
1/15/20257,830,000 shares $72.98 million +6.2%21.5%5.9 $9.32
12/31/20247,370,000 shares $72.37 million +2.8%20.2%5.9 $9.82
12/15/20247,170,000 shares $67.68 million -3.4%19.7%6.1 $9.44
11/30/20247,420,000 shares $64.55 million +1.4%20.4%5.7 $8.70
11/15/20247,320,000 shares $46.63 million -0.1%19.7%5.5 $6.37
10/31/20247,330,000 shares $55.93 million -7.0%20.7%5.4 $7.63
10/15/20247,880,000 shares $61.46 million -3.8%22.2%5.5 $7.80
9/30/20248,190,000 shares $66.87 million +29.0%23.1%5.5 $8.17
9/15/20246,350,000 shares $40.13 million -11.2%17.9%3.6 $6.32
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)

When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.tc pixel

See the stock Musk's own words pointed to right here
8/31/20247,150,000 shares $47.83 million +86.2%20.2%4.5 $6.69
8/15/20243,840,000 shares $974.98 thousand -96.9%10.8%2.6 $0.25
7/31/2024123,460,000 shares $46.91 million +27.0%8.7%2.1 $0.38
7/15/202497,240,000 shares $28.19 million -19.7%6.9%1.6 $0.29
6/30/2024121,100,000 shares $40.48 million -49.2%8.5%2.1 $0.33
6/15/2024238,220,000 shares $107.13 million -2.9%17.0%5.1 $0.45
5/31/2024245,410,000 shares $128.57 million -10.6%17.7%6.1 $0.52
5/15/2024274,440,000 shares $232.09 million -5.3%19.7%7.2 $0.85
4/30/2024289,730,000 shares $258.18 million +8.7%20.8%9.4 $0.89
4/15/2024266,530,000 shares $253.76 million -1.6%19.7%10.8 $0.95
3/31/2024270,830,000 shares $314.16 million +3.3%20.2%12.2 $1.16
3/15/2024262,240,000 shares $283.22 million +2.6%19.6%11.9 $1.08
2/29/2024255,720,000 shares $391.25 million +2.2%19.1%11.2 $1.53
2/15/2024250,230,000 shares $387.86 million +5.6%19.0%11.8 $1.55
1/31/2024236,910,000 shares $286.66 million +1.3%18.0%11.2 $1.21
1/15/2024233,850,000 shares $304.01 million -0.7%17.7%11.1 $1.30
12/31/2023235,500,000 shares $398.00 million -1.5%17.8%12.1 $1.69
12/15/2023239,070,000 shares $382.51 million +3.7%18.1%12.1 $1.60
11/30/2023230,480,000 shares $297.32 million +3.4%17.5%12.4 $1.29
11/15/2023222,910,000 shares $345.51 million -5.5%17.2%11.4 $1.55
10/31/2023235,940,000 shares $323.24 million +2.2%18.6%11.9 $1.37
10/15/2023230,820,000 shares $383.16 million -1.2%18.2%11.6 $1.66
9/30/2023233,540,000 shares $422.71 million -0.4%18.4%10.7 $1.81
9/15/2023234,530,000 shares $452.64 million +13.2%18.5%10.8 $1.93
8/31/2023207,170,000 shares $484.78 million +0.4%16.4%9 $2.34
8/15/2023206,330,000 shares $367.27 million -3.9%16.4%8.5 $1.78
7/31/2023214,590,000 shares $538.62 million -1.4%17.2%9.1 $2.51
7/15/2023217,710,000 shares $444.13 million -2.4%17.4%9.4 $2.04
6/30/2023223,020,000 shares $414.82 million +20.6%17.8%10.3 $1.86
6/15/2023184,920,000 shares $361.52 million +0.9%14.8%8.7 $1.96
5/31/2023183,290,000 shares $289.60 million -9.4%14.7%9.1 $1.58
5/15/2023202,240,000 shares $266.96 million +7.5%16.2%10.1 $1.32
4/30/2023188,130,000 shares $229.52 million -4.4%15.3%10 $1.22
4/15/2023196,750,000 shares $255.78 million +2.1%16.7%10.2 $1.30
3/31/2023192,710,000 shares $256.30 million +11.3%19.1%9.7 $1.33
3/15/2023173,100,000 shares $230.22 million +18.4%17.1%8.3 $1.33
2/28/2023146,150,000 shares $214.84 million +16.8%14.5%6.8 $1.47
2/15/2023125,180,000 shares $227.83 million +1.4%12.4%5.9 $1.82
1/31/2023123,490,000 shares $240.81 million -1.6%12.1%5.3 $1.95
1/15/2023125,510,000 shares $233.45 million -0.6%12.4%5.3 $1.86
12/30/2022126,250,000 shares $213.36 million +10.5%12.5%5.2 $1.69
12/15/2022114,290,000 shares $186.29 million -3.6%11.0%4.5 $1.63
11/30/2022118,570,000 shares $235.95 million -4.7%12.6%4.8 $1.99
11/15/2022124,380,000 shares $332.09 million -7.3%13.2%5 $2.67
10/31/2022134,220,000 shares $366.42 million -14.1%15.7%4.9 $2.73
10/15/2022156,300,000 shares $404.82 million -8.8%19.2%5.9 $2.59
9/30/2022171,280,000 shares $534.39 million -8.7%24.2%6.8 $3.12
9/15/2022187,610,000 shares $587.22 million +4.8%22.1%7.4 $3.13
8/31/2022179,060,000 shares $481.67 million +24.1%22.8%7 $2.69
8/15/2022144,250,000 shares $503.43 million -4.0%18.4%5.5 $3.49
I’m sounding the alarm (Ad)

Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.tc pixel

Watch Stansberry's full investigation and see which companies to buy and sell
7/31/2022150,270,000 shares $429.77 million +3.9%19.8%6.5 $2.86
7/15/2022144,640,000 shares $433.92 million +7.5%19.1%6.2 $3.00
6/30/2022134,540,000 shares $320.21 million +22.4%17.8%5.7 $2.38
6/15/2022109,920,000 shares $284.69 million -14.7%14.6%4.3 $2.59
5/31/2022128,780,000 shares $396.64 million +19.1%17.1%5.6 $3.08
5/15/2022108,160,000 shares $287.71 million +16.9%14.4%5.2 $2.66
4/30/202292,500,000 shares $268.25 million +13.8%11.8%5 $2.90
4/15/202281,300,000 shares $312.19 million +9.7%10.3%4.6 $3.84
3/31/202274,120,000 shares $298.70 million -16.4%9.4%4.4 $4.03
3/15/202288,670,000 shares $258.03 million +2.9%9.3%7.1 $2.91
2/28/202286,190,000 shares $387.86 million +1.5%9.4%7.3 $4.50
2/15/202284,950,000 shares $471.47 million -9.2%9.2%7.5 $5.55
1/31/202293,570,000 shares $559.55 million +30.3%10.2%8.9 $5.98
1/15/202271,830,000 shares $415.90 million +30.0%8.6%8.2 $5.79
12/31/202155,270,000 shares $459.29 million No Change6.4%7 $8.31

DNA Short Interest - Frequently Asked Questions

Short interest is the volume of Ginkgo Bioworks shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 5,233,195 shares of DNA short. 9.68% of Ginkgo Bioworks' shares are currently sold short. Learn More on Ginkgo Bioworks' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DNA shares currently have a short interest ratio of 5.0. Learn More on Ginkgo Bioworks's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.68% of Ginkgo Bioworks' floating shares are currently sold short.

Ginkgo Bioworks saw a decrease in short interest in April. As of April 30th, there was short interest totaling 5,233,195 shares, a decrease of 14.2% from the previous total of 6,098,868 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

9.68% of Ginkgo Bioworks' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ginkgo Bioworks: Twist Bioscience Corporation (23.06%), Adaptive Biotechnologies Corporation (5.59%), Nanobiotix S.A. - Sponsored ADR (0.08%), Bausch Health Cos Inc. (2.15%), Ocular Therapeutix, Inc. (11.59%), Zai Lab Limited Unsponsored ADR (4.13%), Sarepta Therapeutics, Inc. (25.35%), Trevi Therapeutics, Inc. (13.18%), Stoke Therapeutics, Inc. (23.12%), Tyra Biosciences, Inc. (14.81%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling DNA is an investing strategy that aims to generate trading profit from Ginkgo Bioworks as its price is falling. DNA shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ginkgo Bioworks occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DNA, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like DNA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:DNA) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Veteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...
Profits Run | Sponsoredtc pixel
Distracted Americans set to miss out on quadrillions
Technology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...
Brownstone Research | Sponsoredtc pixel
The one number Musk can't hide in the S-1
When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...
Behind the Markets | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel